AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Cabotegravir in South Africa
3 products registered with SAHPRA — 3 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| VOCABRIA 600 mg SUSPENSION FOR INJECTION | 56/20.2.8/0125 | GlaxoSmithKline South Africa (Pty) Limited | active | 4 Jul 2028 |
| VOCABRIA 400 mg SUSPENSION FOR INJECTION | 56/20.2.8/0124 | GlaxoSmithKline South Africa (Pty) Limited | active | 4 Jul 2028 |
| APRETUDE 600 mg/3 ml | 56/20.2.8/0979 | GlaxoSmithKline South Africa (Pty) Limited | active | 22 Nov 2027 |
Cabotegravir — SAHPRA Registration Details
SAHPRA (South Africa) has 3 registered products containing Cabotegravir, of which 3 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Cabotegravir registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.